Bench Mark Infotech Services IPO Final Day: GMP ₹12
It’s here – Day 5, the grand finale for the Bench Mark Infotech Services SME IPO on the NSE. Today marks the last chance for investors to bid for shares at the issue price of ₹110. As we close the subscription window, it’s crucial to look at where we stand. The subscription numbers are currently sitting at a flat 0x across all categories – Retail, NII, and QIB. This is an interesting development on the final day, and we’ll delve into what it might signify. The Grey Market Premium (GMP) remains steady at ₹12, suggesting a potential listing price of ₹122, a modest gain from the issue price. Let’s break down these figures and help you make that final decision.
| Date | GMP | Est. Listing |
|---|---|---|
| 05 Oct | +₹29 | ₹139 |
| 03 Oct | +₹29 | ₹139 |
| 02 Oct | +₹12 | ₹122 |
| 01 Oct | +₹12 | ₹122 |
| 30 Sep | +₹12 | ₹122 |
Subscription Status
The subscription figures on closing day are, to put it mildly, perplexing. With all categories showing a 0x subscription, it indicates that as of our last update, no bids have been formally registered. This is highly unusual for an SME IPO, especially on its final day. Typically, you’d expect at least some retail interest to materialize, if not robust NII or QIB participation. The absence of any subscription could mean a few things. It might suggest that the IPO hasn’t generated significant buzz, or perhaps investors are waiting until the very last minute to place their bids, which is quite a gamble. Alternatively, it could point to an issue with the bidding platform or a technical glitch, though we haven’t received any official reports to that effect. The lack of QIB and NII interest, in particular, can sometimes be a red flag, as these are often institutional players who conduct thorough due diligence. However, given the flat 0x across the board, it’s more likely a case of delayed or absent retail participation for now. We’ll need to see the final tally once the window closes to get a true picture.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 0.00x | |
| NII / HNI | 0.00x | |
| QIB | 88.62x | |
| Total | 88.62x |
GMP Update
The Grey Market Premium (GMP) for Bench Mark Infotech Services has held firm at ₹12 for the past day. This means that, in the unofficial grey market, investors are willing to pay ₹12 above the issue price of ₹110, valuing the stock at ₹122. This is a positive sign, indicating a potential listing gain. A ₹12 GMP on an issue price of ₹110 translates to a roughly 10.9% gain. While not spectacular, it’s a decent return and suggests that the market sentiment, at least in the grey market, is leaning towards a positive debut. The fact that it remained unchanged from yesterday, despite the unusual subscription numbers, is also worth noting. It suggests that the GMP is somewhat detached from the immediate subscription activity and is likely driven by broader market sentiment or specific analyst views on the company’s fundamentals.
Should You Apply?
This is where it gets tricky. On one hand, the GMP is offering a potential upside, hinting at a listing price of ₹122. This could be attractive for short-term traders looking for a quick gain. However, the subscription status on closing day is a significant concern. Zero subscriptions across all categories is highly unconventional and doesn’t inspire much confidence, especially if it holds true in the final numbers. It’s crucial to remember that the SEBI advisor strictly recommends that investors should only invest in IPOs after doing thorough research and understanding the risks involved. The lack of subscription data might mean that either the IPO hasn’t caught the eye of investors, or there’s a last-minute surge expected. Without more concrete subscription data, relying solely on the GMP can be risky. You’ll want to check the final subscription figures as soon as they are released after market close. If the subscription remains extremely low, it might be prudent to wait and observe the stock’s performance post-listing rather than jumping in at the IPO stage. Weigh the potential gains against the uncertainty presented by the current subscription scenario.